Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...

The recent announcement by PSA regarding delays in their recieving process has caused a stir among collectors, which has led to the consideration of alternative grading companies by collectors as well ...